A new vitamin and mineral complex (a dietary supplement) has been developed. The active ingredients include magnesium oxide, vitamin C, zinc oxide, chromium picolinate, manganese sulfate, boron, hydroxyapatite calcium, silicon oxide, cholecalciferol, and chondroitin sulfate. The pharmaceutical formulation was carefully calculated taking into account biochemical properties of all the ingredients. The clinical trial was performed to evaluate the functional properties and efficacy of the supplement. The participants of the trial included patients with long bone fractures aged 3-7 (one capsule per day) and aged 8-14 (two capsules per day).
During the clinical trial various parameters were assessed. The levels of phosphorus, ionized calcium and alkaline phosphatase were tested and X-rays and laser Doppler flowmetry were employed. The dietary supplement helped to lessen the intensity of pain and swelling, therefore, the use of analgesics was limited and the treatment period was reduced. By the end of the treatment, biochemical parameters were within reference ranges. The study findings indicate the positive impact of mineral complex (the dietary supplement) and the new vitamin on bone tissue regeneration and the recovery processes as well as prevention of tropic changes in soft tissue and post-traumatic edema development. The recommendations on the safe use of the dietary supplement were developed. The dietary supplement is manufactured by the scientific research-to-production facilities of Art-Life scientific production association in the city of Tomsk. The manufacturing process is carried out in full compliance with ISO 9001, 22000, GMP to guarantee the product quality and competitiveness.
IJPRAS
